APA (7th ed.) Citation

Poliseno, M., Caputo, S. L., Tavelli, A., Gagliardini, R., Gazzola, L., Saracino, A., . . . Cozzi-Lepri, A. (2025). Long-term trajectories of hepatic and metabolic biomarkers after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral therapy-experienced people with HIV with and without hepatic coinfection: Data from the ICONA cohort. International journal of infectious diseases, 161, 108081. https://doi.org/10.1016/j.ijid.2025.108081

Chicago Style (17th ed.) Citation

Poliseno, Mariacristina, et al. "Long-term Trajectories of Hepatic and Metabolic Biomarkers After Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Antiretroviral Therapy-experienced People with HIV with and Without Hepatic Coinfection: Data from the ICONA Cohort." International Journal of Infectious Diseases 161 (2025): 108081. https://doi.org/10.1016/j.ijid.2025.108081.

MLA (9th ed.) Citation

Poliseno, Mariacristina, et al. "Long-term Trajectories of Hepatic and Metabolic Biomarkers After Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Antiretroviral Therapy-experienced People with HIV with and Without Hepatic Coinfection: Data from the ICONA Cohort." International Journal of Infectious Diseases, vol. 161, 2025, p. 108081, https://doi.org/10.1016/j.ijid.2025.108081.